Gara Jalqabaatti › Hidradenitis Suppurativa › Illinois
Qorannoo klinikaalii Hidradenitis Suppurativa Illinois keessatti
Qorannoo 6 Hidradenitis Suppurativa f Illinois keessatti hirmaatuu jiru.
Magaalota Illinois keessatti
Takkalaa qorannoo (Ingiliffa)
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- Endeavor Health, Glenview
- Dundee Dermatology, West Dundee
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 79 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07783542A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- NorthShore University Health System - Endeavor Health Medical Group - Skokie - Woods Drive- Site Number : 8400019, Skokie
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07225569Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US125, Chicago
- Investigative Site US093, Chicago
- Investigative Site US039, West Dundee
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06855498Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Endeavor Health Medical Group, Skokie
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 hanga 17 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07213973A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Northwestern University, Chicago
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 71 · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT07123038Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.